1. Defazio G, Hallett M, Jinnah HA, Conte A, Berardelli A. Blepharospasm 40 years later. J Move Disorder Soc. 2017;32(4):498-509. [
DOI:10.1002/mds.26934] [
PMID] [
PMCID]
2. Karp BI, Alter K. Botulinum toxin treatment of blepharospasm, orofacial/oromandibular dystonia, and hemifacial spasm. Seminars Neurol. 2016;36(1):84-91. [
DOI:10.1055/s-0036-1571952] [
PMID]
3. Ramirez-Castaneda J, Jankovic J. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. J Int Soc Toxinol. 2014;90:344-8. [
DOI:10.1016/j.toxicon.2014.07.009] [
PMID]
4. Defazio G, Hallett M, Jinnah HA, Berardelli A. Development and validation of a clinical guideline for diagnosing blepharospasm. Neurol. 2013;81(3):236-40. [
DOI:10.1212/WNL.0b013e31829bfdf6] [
PMID] [
PMCID]
5. Schwingenschuh P, Katschnig P, Edwards MJ, et al. The blink reflex recovery cycle differs between essential and presumed psychogenic blepharospasm. Neurol. 2011;76(7):610-4. [
DOI:10.1212/WNL.0b013e31820c3074] [
PMID] [
PMCID]
6. Conte A, Fabbrini G, Belvisi D, Marsili L, Di Stasio F, Berardelli A. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm. Europ J Neurol. 2010;17(3):449-55. [
DOI:10.1111/j.1468-1331.2009.02840.x] [
PMID]
7. Grandas F, Traba A, Alonso F, Esteban A. Blink reflex recovery cycle in patients with blepharospasm unilaterally treated with botulinum toxin. Clin Neuropharmacol. 1998;21(5):307-11.
8. Tolosa E, Montserrat L, Bayes A. Blink reflex studies in focal dystonias: enhanced excitability of brainstem interneurons in cranial dystonia and spasmodic torticollis. J Move Disorder Soc. 1988;3(1):61-9. [
DOI:10.1002/mds.870030108] [
PMID]
9. Aramideh M, Eekhof JL, Bour LJ, Koelman JH, Speelman JD, Ongerboer de Visser BW. Electromyography and recovery of the blink reflex in involuntary eyelid closure: a comparative study. J Neurol Neurosurg Psychiatr. 1995;58(6):692-8. [
DOI:10.1136/jnnp.58.6.692] [
PMID] [
PMCID]
10. Eekhof JL, Aramideh M, Bour LJ, Hilgevoord AA, Speelman HD, Ongerboer de Visser BW. Blink reflex recovery curves in blepharospasm, torticollis spasmodica, and hemifacial spasm. Muscle Nerve. 1996;19(1):10-5.
https://doi.org/10.1002/(SICI)1097-4598(199601)19:1<10::AID-MUS2>3.0.CO;2-B [
DOI:10.1002/(SICI)1097-4598(199601)19:13.0.CO;2-B]
11. Mahdizadeh F, Mehraban AH, Faranoush M, Amini M, Mehdizadeh M. Fatigue in Children with Cancer: Reliability and Validity of the Persian Version of Child, Parent, and Staff Fatigue Scale. Asia-Pacific Journal of Oncology Nursing. 2020;7(2):174. [
DOI:10.4103/apjon.apjon_44_19] [
PMID] [
PMCID]
12. Mehdizadeh M, Fereshtehnejad S-M, Goudarzi S, Moshtagh A, Dehghanian Nasrabadi F, Habibi SAH, et al. Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson's Disease. Parkinson's Disease. 2020;2020. [
DOI:10.1155/2020/2793945] [
PMID] [
PMCID]
13. Mehdizadeh M, Martinez-Martin P, Habibi SA, Nikbakht N, Alvandi F, Bazipoor P, et al. The association of balance, fear of falling, and daily activities with drug phases and severity of disease in patients with Parkinson. Basic and clinical neuroscience. 2019;10(4):355. [
DOI:10.32598/bcn.9.10.295] [
PMID] [
PMCID]
14. Mehdizadeh M, Mehraban AH, Zahediyannasab R. The effect of group-based occupational therapy on performance and satisfaction of stroke survivors: pilot trail, neuro-occupational view. Basic and clinical neuroscience. 2017;8(1):69. [
DOI:10.15412/J.BCN.03080109] [
PMID] [
PMCID]
15. Taghizadeh G, Martinez-Martin P, Meimandi M, Habibi SAH, Jamali S, Dehmiyani A, et al. Barthel Index and modified Rankin Scale: Psychometric properties during medication phases in idiopathic Parkinson disease. Annals of Physical and Rehabilitation Medicine. 2019. [
DOI:10.1016/j.rehab.2019.08.006] [
PMID]
16. Azad A, Mohammadinezhad T, Taghizadeh G, Lajevardi L. Clinical assessment of activities of daily living in acute stroke: Validation of the Persian version of Katz Index. Medical journal of the Islamic Republic of Iran. 2017; 31:30. [
DOI:10.18869/mjiri.31.30] [
PMID] [
PMCID]
17. Sommer M, Ferbert A. The stimulus intensity modifies the blink reflex recovery cycle in healthy subjects and in blepharospasm. Int Federation Clin Neurophysiol. 2001;112(12):2293-9. [
DOI:10.1016/S1388-2457(01)00701-5]
18. Yaman M, Sahin S, Kiziltan ME. Blink reflex recovery in central and peripherally originated movement disorders of the cranio-cervical area: a comparative study. Electromyograph Clin Neurophysiol. 2009;49(1):19-25.
19. Basso MA, Powers AS, Evinger C. An explanation for reflex blink hyperexcitability in Parkinson's disease. I. Superior Colliculus. J Neurosci. 1996;16(22):7308-17. [
DOI:10.1523/JNEUROSCI.16-22-07308.1996] [
PMID] [
PMCID]
20. Curra A, Bagnato S, Berardelli A. Recent findings in cranial and cervical dystonia: how they help us to understand the pathophysiology of dystonia. Supp Clin Neurophysiol. 2006;58:257-65. [
DOI:10.1016/S1567-424X(09)70074-1]
21. Hwang CJ, Eftekhari K. Benign essential blepharospasm: what we know and what we don't. Int Ophthalmol Clin. 2018;58(1):11-24. [
DOI:10.1097/IIO.0000000000000207] [
PMID]
22. Quartarone A, Sant'Angelo A, Battaglia F, et al. Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm. J Neurosci Soc Neurosci. 2006;26(2):716-21. [
DOI:10.1523/JNEUROSCI.3948-05.2006] [
PMID] [
PMCID]
23. Defazio G, Conte A, Gigante AF, et al. Clinical heterogeneity in patients with idiopathic blepharospasm: A cluster analysis. Parkinsonism Relat Disorder. 2017;40:64-8. [
DOI:10.1016/j.parkreldis.2017.04.014] [
PMID]
24. Ferrazzano G, Conte A, Gigante A, Defazio G, Berardelli A, Fabbrini G. Disease progression in blepharospasm: a 5-year longitudinal study. Europ J Neurol. 2019;26(2):268-73. [
DOI:10.1111/ene.13832] [
PMID]